iifl-logo

PGIM India Healthcare Fund Direct G

PGIM India Healthcare Fund Direct G

Fund Name

PGIM India Mutual Fund

Scheme Name

PGIM India Healthcare Fund Direct G

AMC

PGIM India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

19-Nov-2024

Fund Manager

Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

108.88

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

PGIM India Healthcare Fund Direct G - Nav Details

Nav Date

:  26-Jun-2025

NAV [Rs.]

:  9.88

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Direct G- NAV Chart

PGIM India Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.96
1.85
4.77
-1.29
-
-
-
-1.19
Category Avg
1.89
1.69
4.95
-2.1
17.82
25.81
22.2
17.79
Category Best
2.96
2.66
12.9
1.96
29.11
30.63
25.34
35.69
Category Worst
0.34
0.73
0.8
-6.37
5.63
20.99
16.92
-4.55

PGIM India Healthcare Fund Direct G- Latest Dividends

No Records Found

PGIM India Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Dr Agarwal's Eye576

Out

InName Of The CompanyNo Of Shares
Sanofi Consumer3,936

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.748270813.87
EquityDivi's Lab.Pharmaceuticals & Biotechnology8.60141569.35
EquityMax HealthcareHealthcare Services7.19695917.83
EquityDr Reddy's LabsPharmaceuticals & Biotechnology6.31548916.86
EquityAster DM Health.Healthcare Services5.231018495.69
EquityMankind PharmaPharmaceuticals & Biotechnology5.09224455.53
EquityTorrent Pharma.Pharmaceuticals & Biotechnology3.90133804.24
EquityKrishna Institu.Healthcare Services3.68585774.00
EquityAbbott IndiaPharmaceuticals & Biotechnology3.3211883.61
EquityAjanta PharmaPharmaceuticals & Biotechnology3.28142403.57
EquityJ B Chemicals &Pharmaceuticals & Biotechnology3.24210143.52
EquityPB Fintech.Financial Technology (Fintech)3.06189423.33
EquityGlobal HealthHealthcare Services2.89264713.14
EquityICICI LombardInsurance2.82163883.07
EquityCiplaPharmaceuticals & Biotechnology2.65197002.88
EquityJupiter Life LinHealthcare Services2.49184802.70
EquityDr Lal PathlabsHealthcare Services2.4294452.63
EquityNavin Fluo.Intl.Chemicals & Petrochemicals2.2457312.44
EquityIpca Labs.Pharmaceuticals & Biotechnology2.10160842.29
EquitySyngene Intl.Healthcare Services2.08350052.26
EquityRainbow Child.Healthcare Services1.94150352.10
EquitySagility IndiaIT - Services1.824999081.97
EquityNeuland Labs.Pharmaceuticals & Biotechnology1.7916941.94
EquitySanofi IndiaPharmaceuticals & Biotechnology1.6528971.79
EquitySai LifePharmaceuticals & Biotechnology1.32189841.43
EquityZydus Lifesci.Pharmaceuticals & Biotechnology1.01117661.09
EquityOrchid PharmaPharmaceuticals & Biotechnology0.68118050.74
EquityAkums DrugsPharmaceuticals & Biotechnology0.3260410.34
EquityDr Agarwal's EyeHealthcare Services0.235760.25
Cash & Cash Equivalent
Reverse RepoC C I-/-2.7402.98
Reverse RepoC C I-/-0.8200.89
Net CA & OthersNet CA & Others-/-0.3500.38

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
24,164.95
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Mr. Ajit Menon
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.